Eslicarbazepine acetate (trade names Aptiom in the US, Zebinix in Europe, Exalief in Russia), abbreviated as ESL, is an anticonvulsant medication approved for use in Europe and the United States as monotherapy or adjunctive therapy (additional therapy) for partial-onset seizures epilepsy....Wikipedia

 

 

Manufacturer's Website: Aptiom

 

 

Average retail cost: $861/month

Search Terms: Aptiom, eslicarbazepine acetate, seizures, anticonvulsant, epilepsy